Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs
Kailera Therapeutics’ IPO proceeds will help world medical trials for its weight problems drug candidates. In the meantime, proteomics firm ...
Kailera Therapeutics’ IPO proceeds will help world medical trials for its weight problems drug candidates. In the meantime, proteomics firm ...
Flagship Pioneering-founded Generate Biomedicines goals to supply much less frequent injections in comparison with a blockbuster bronchial asthma drug from ...
This might be the largest week for biotech IPOs in years — even when the federal government stays shuttered quickly. ...
For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology ...
The dam finally seems to be breaking in the digital health world. There was a surge of digital health companies ...
Chronic care management company Omada Health is seeking a valuation of about $1.1 billion with its initial public offering on the ...
Digital musculoskeletal care company Hinge Health, went public today on the NYSE under the symbol HNGE, raising around $437.3 million ...
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.